Symbol="CMPX"
AssetType="Common Stock"
Name="Compass Therapeutics Inc."
Description="Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple human diseases. The company is headquartered in Boston, Massachusetts."
CIK="1738021"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="245 FIRST STREET, 3RD FLOOR, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="337774000"
EBITDA="-43373000"
PERatio="None"
PEGRatio="None"
BookValue="1.387"
DividendPerShare="0"
DividendYield="0"
EPS="-0.34"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.165"
ReturnOnEquityTTM="-0.258"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.34"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="9.17"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.684"
EVToRevenue="-"
EVToEBITDA="-11.0"
Beta="0.428"
num_52WeekHigh="5.65"
num_52WeekLow="1.81"
num_50DayMovingAverage="3.017"
num_200DayMovingAverage="3.631"
SharesOutstanding="126507000"
DividendDate="None"
ExDividendDate="None"
symbol="CMPX"
open="2.50"
high="2.69"
low="2.50"
price="2.67"
volume="343777.00"
latest_trading_day="2023-07-28"
previous_close="2.49"
change="0.18"
change_percent="7.2289%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="72"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="28"
Volume_recent_avg="505141"
Change_recent_avg="-0.01"
Delta_recent_avg="0.2"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="-0.46"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="28"
Aroon_momentum_negative="72"
image_negative_thumbnail_id_1="158"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0018.jpeg"
image_negative_thumbnail_id_2="1087"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0120.jpeg"
image_neutral_thumbnail_id_1="550"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_neutral_thumbnail_id_2="522"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0077.jpeg"
image_positive_thumbnail_id_1="648"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0060.jpeg"
image_positive_thumbnail_id_2="607"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0101.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
